Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als)
CA 2469092 C · Owner: Yeda Research And Development Co. Ltd · Inventors: Yoles, Esther; Eisenbach-Schwartz, Michal
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A vaccine for reducing disease progression and/or protection of motor nerve , degeneration and/or protection from glutamate toxicity in motor neurone disease (MND), particularly amyotrophic lateral sclerosis (ALS) patients, comprising an active agent selected from the group consisting of Cop 1 a Cop , 1-related peptide, a Cop 1-related polypeptide and poly-Glu,Tyr. The active , agent is preferably Cop 1 or poly-Glu,Tyr and can be administered with or , without an adjuvant.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 5, 2002 and granted February 19, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 5, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 5, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.